| scholarly article | Q13442814 |
| P2093 | author name string | Samir K Ballas | |
| P2860 | cites work | Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. | Q39154540 |
| Efficacy of tramadol vs meperidine in vasoocclusive sickle cell crisis | Q39285954 | ||
| Cannabis use in sickle cell disease: a questionnaire study | Q39361744 | ||
| Non-pharmacologic management of sickle cell pain | Q39379442 | ||
| Comparison of intramuscular analgesic activity of butorphanol and morphine in patients with sickle cell disease | Q39531021 | ||
| Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect | Q42069052 | ||
| Cannabis in Pain Treatment: Clinical and Research Considerations. | Q45998776 | ||
| Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports | Q47380075 | ||
| A randomized controlled trial of massage therapy in children with sickle cell disease. | Q50752669 | ||
| Randomised trial of oral morphine for painful episodes of sickle-cell disease in children | Q73868175 | ||
| [Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease] | Q86889936 | ||
| Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy | Q24187798 | ||
| The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS | Q24197970 | ||
| Medical marijuana: clearing away the smoke | Q24617731 | ||
| Adverse effects of medical cannabinoids: a systematic review | Q24644380 | ||
| Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials | Q26778552 | ||
| The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy | Q26779350 | ||
| Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia | Q28540243 | ||
| Cannabinoids for Medical Use | Q29391539 | ||
| Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members | Q30459060 | ||
| Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation | Q30773183 | ||
| Purified poloxamer 188 for sickle cell vaso-occlusive crisis | Q31038001 | ||
| Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. | Q34033859 | ||
| Sickle cell pain: a critical reappraisal | Q34296026 | ||
| Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home | Q34424675 | ||
| Medical marijuana in neurology | Q34449698 | ||
| Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review | Q34481944 | ||
| Daily assessment of pain in adults with sickle cell disease | Q34736115 | ||
| Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial | Q36112390 | ||
| A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. | Q36115743 | ||
| Pain management of sickle cell disease | Q36281512 | ||
| The prevalence of marijuana smoking in young adults with sickle cell disease: a longitudinal study. | Q36716868 | ||
| A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes | Q37144863 | ||
| Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation | Q37216210 | ||
| Goals and habits in the brain | Q38153878 | ||
| Low-molecular-weight heparins for managing vasoocclusive crises in people with sickle cell disease: a summary of a cochrane systematic review. | Q38211660 | ||
| Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease | Q38257400 | ||
| Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. | Q38503842 | ||
| Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence | Q38577921 | ||
| The Changing Drug Culture: Medical and Recreational Marijuana | Q38735575 | ||
| Cannabinoids: Medical implications | Q38749077 | ||
| A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications | Q38937106 | ||
| P433 | issue | 1 | |
| P921 | main subject | sickle-cell disease | Q185034 |
| hospitalization | Q3140971 | ||
| P304 | page(s) | 197-201 | |
| P577 | publication date | 2017-07-01 | |
| P1433 | published in | Cannabis and cannabinoid research | Q27727510 |
| P1476 | title | The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises | |
| P478 | volume | 2 |
Search more.